| Direct marketing provides bright spot in Harte-Hanks’ Q3 results
Direct marketing company Harte-Hanks Inc. reported that operating revenue for the three months ended September 30 declined 2.7% for a total of $286.7 million. Net income dropped during the same period by 20.9% for a total of $21.9 million. Diluted earnings per share dropped 14.3% to $0.35 per share. During the nine-month period ended September 30, the company's revenues were down 1.3% for a total of $859.9 million. Diluted earnings per share during the same period were $0.87 compared to $1 for the 2006 nine-month period. The company's direct marketing revenue was up 4.1% during the third quarter. The direct marketing segment incurred approximately $1.6 million in restructuring costs in connection with flattening the organization to make it more efficient and bringing sales, marketing and operations closer to customers.
Blame it on Nixon
The Battle of Alberta got off to a rockin' start just three second in when Hitmen rookie Ian Schultz and Oil Kings defenceman Cameron Cepek dropped the mitts and helmets off the opening faceoff. With the two players nowhere near each other -- Schultz started at right wing, Cepek on right defence -- it was clear the scrap wasn't exactly spontaneous. Schultz, who was later forced to leave the game after being clipped by a high stick, said the bout's origin dated back to last Sunday's game at Rexall Place in Edmonton. "Cepek asked me last game to go off the opening faceoff, but I said 'no' because I had hurt my hand a couple of games before," said Schultz, who recorded the knockdown victory. "After the national anthem, we kind of gave each other the nod and that was it." Nixon had spent his entire career in Kamloops prior to being shipped to Calgary for 17-year-old winger Devon Kalinski.
Roses & Raspberries
A tournament was held at Triple Threat and the fifth-grade team won the championship in their division! My daughter and I have been in their league for two years now and we want to thank them for all the hard work put into promoting girls' basketball in Pennfield. - Melanie and Katrina Brann To everyone who purchased the Pennfield Lions Club's Giant Coloringbooks. All money from this fundraiser goes to help the Food Bank. Thanks especially go to JoAnn and Newt at the Pancake House, Becky and Steve at Shrank's Cafeteria, and to Brent Walker owner of the Pennfield Shell. Opening your doors helped make this fundraiser a huge success. - Mike Cole, treasurer, Pennfield Lions Club To Battle Creek Community Foundation and Brenda Hunt, CEO, for stepping up and helping save Burnham Brook senior building and programs.
How to determine the strength of a foodborne illness claim
William Marler is the managing partner of Marler Clark LLP, PS. Since 1993, Mr. Marler has represented thousands of persons who have become ill with E. coli, Salmonella, Hepatitis A, Listeria, Shigella, Campylobacter or Norovirus illnesses in over thirty states. As a trial lawyer, Mr. Marler has been involved in several cases of national importance. He represented a nine-year-old girl in her $15.6 million E. coli settlement with Jack-in-the-Box. This settlement created a Washington State record for an individual personal injury action. Mr. Marler resolved several other Jack-in-the-Box E. coli cases for more than $2.5 million each. In May of 1998, Mr. Marler settled claims on behalf of the families of several children who were severely injured after consuming E. coli O157:H7-contaminated Odwalla apple juice for a reported $12 million.
LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19 ...
BURLINGTON, Mass., Nov. 5 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ: LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced Q3 2007 financial results. Revenues for Q3 2007 were $10.1 million, an increase of 19% over Q3 2006. Q3 2007 revenues increased 33% in the Company's Endovascular and Dialysis Access category, 15% in the Vascular category, and 3% in the General Surgery category. Sales growth was driven by the continued acceleration of the endovascular procedure market, relatively strong sales within the vascular category, productivity gains from recently hired sales representatives, and the distribution of the Powerlink stent graft in Europe. For Q3 2007, the Company reported a gross margin of 74.7%, versus 73.3% in Q3 2006.
|
